Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease

Approximately 30% of dogs being treated for heart disease and CHF satisfied the definition of ABT. Identifying patient subpopulations experiencing ABT may help guide future study design and clinical decision-making.